[go: up one dir, main page]

MXPA01007949A - Regulacion de anestesia. - Google Patents

Regulacion de anestesia.

Info

Publication number
MXPA01007949A
MXPA01007949A MXPA01007949A MXPA01007949A MXPA01007949A MX PA01007949 A MXPA01007949 A MX PA01007949A MX PA01007949 A MXPA01007949 A MX PA01007949A MX PA01007949 A MXPA01007949 A MX PA01007949A MX PA01007949 A MXPA01007949 A MX PA01007949A
Authority
MX
Mexico
Prior art keywords
anaesthesia
subject
regulation
delta
inducing peptide
Prior art date
Application number
MXPA01007949A
Other languages
English (en)
Inventor
Michael Alkire
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9902469.7A external-priority patent/GB9902469D0/en
Application filed by Univ Manchester filed Critical Univ Manchester
Publication of MXPA01007949A publication Critical patent/MXPA01007949A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a los usos de compuestos que modulan el activo de peptido inductor del sueño delta para regular la anestesia y metodos para evaluar las necesidades anestesicas de un sujeto que comprenden hacer pruebas en una muestra que se toma del sujeto para la presencia del peptido inductor del sueño delta.
MXPA01007949A 1999-02-05 2000-02-01 Regulacion de anestesia. MXPA01007949A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9902469.7A GB9902469D0 (en) 1999-02-05 1999-02-05 Brain metabolism
US12032699P 1999-02-17 1999-02-17
US15566199P 1999-09-24 1999-09-24
PCT/GB2000/000281 WO2000045832A2 (en) 1999-02-05 2000-02-01 Regulation of anaesthesia

Publications (1)

Publication Number Publication Date
MXPA01007949A true MXPA01007949A (es) 2003-06-04

Family

ID=27269636

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01007949A MXPA01007949A (es) 1999-02-05 2000-02-01 Regulacion de anestesia.

Country Status (15)

Country Link
EP (1) EP1148887A2 (es)
JP (1) JP2002536337A (es)
KR (1) KR20010101992A (es)
CN (1) CN1346278A (es)
AP (1) AP2001002245A0 (es)
AU (1) AU2445900A (es)
BR (1) BR0008046A (es)
CA (1) CA2360124A1 (es)
ID (1) ID30518A (es)
IL (1) IL144572A0 (es)
MX (1) MXPA01007949A (es)
NO (1) NO20013795L (es)
OA (1) OA11758A (es)
TR (1) TR200102265T2 (es)
WO (1) WO2000045832A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
JP2010539071A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト チモシンβ４とデルタ睡眠誘発ペプチドとのペプチドの組合せの、治療剤としての使用
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
CN108376559B (zh) * 2018-02-28 2020-10-16 复旦大学附属中山医院 乙醛脱氢酶2基因型在麻醉剂量计算中的应用
CN112535727A (zh) * 2020-12-24 2021-03-23 安域生物制药(杭州)有限公司 一种具有睡眠改善作用的短肽凝胶及其制备方法
CN112908454B (zh) * 2021-02-26 2023-08-29 西安交通大学口腔医院 一种智能保管麻醉剂的方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (de) * 1977-06-30 1983-01-31 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung.
CA1188989A (en) * 1981-05-21 1985-06-18 Richard R. Scherschlicht Nonapeptide for the treatment of drug withdrawal symptoms
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
RU2104717C1 (ru) * 1995-07-07 1998-02-20 Новокузнецкий государственный институт усовершенствования врачей Способ анестезии при операциях у больных с синдромом лериша

Also Published As

Publication number Publication date
KR20010101992A (ko) 2001-11-15
BR0008046A (pt) 2001-11-06
NO20013795D0 (no) 2001-08-02
WO2000045832A2 (en) 2000-08-10
ID30518A (id) 2001-12-13
NO20013795L (no) 2001-08-02
AP2001002245A0 (en) 2001-09-30
OA11758A (en) 2005-07-19
CN1346278A (zh) 2002-04-24
TR200102265T2 (tr) 2001-12-21
CA2360124A1 (en) 2000-08-10
JP2002536337A (ja) 2002-10-29
EP1148887A2 (en) 2001-10-31
IL144572A0 (en) 2002-05-23
AU2445900A (en) 2000-08-25
WO2000045832A3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
EP1015039A4 (en) MEANS OF OXYGEN DELIVERY AND THEIR APPLICATION
WO2001085664A3 (en) Compounds and methods for regulating bacterial growth and pathogenesis
ATE394082T1 (de) Vorrichtung zur verbindung von wirbeln der wirbelsäule
IL175770A0 (en) Novel use of peptide compounds for treating central neuropathic pain
MY129015A (en) Process for coating stents and other medical devices using super-critical carbon dioxide
WO2003002717A3 (en) Biological activity of ak155
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
BG103886A (en) Regulation of the expression of quinolate phospho- ribosyltransferase
WO2003028521A3 (en) Electrode system for neural applications
WO1999025817A3 (en) Tc1-based transposon vectors
GR3035227T3 (en) Neuroactive peptides
EP0939632A4 (en) NON-PEPTIDIC VASOPRESSIN VIA ANTAGONISTS
DE69824433D1 (en) Proteintyrosinphosphatase inhibitoren
MXPA01007949A (es) Regulacion de anestesia.
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
DK1372445T3 (da) Madlavningsapparat
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
GR3031104T3 (en) Suspension concentrate compositions of arylpyrrole insecticidal and acaricidal agents.
WO2002066045A3 (en) Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a
DK0852153T3 (da) Indretning til udskiftning af ventilationssonder i en patients luftrør
DE69724062D1 (de) Benzothiophenderivate, Zwischenprodukte, Verfahren, Zubereitungen und Methoden
GB0115382D0 (en) Mutant
WO2001012838A3 (en) Compounds which modulate the activity of an lpa receptor
MXPA01003246A (es) Receptor para factor oostatico de modulacion de trispsina y uso del mismo.
GB2344107A (en) Gene